127 related articles for article (PubMed ID: 16092934)
1. Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis.
Sucic S; Bryan-Lluka LJ
J Neurochem; 2005 Sep; 94(6):1620-30. PubMed ID: 16092934
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants.
Sucic S; Bryan-Lluka LJ
Eur J Pharmacol; 2007 Feb; 556(1-3):27-35. PubMed ID: 17141753
[TBL] [Abstract][Full Text] [Related]
3. Amino acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters.
Paczkowski FA; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):312-7. PubMed ID: 11919656
[TBL] [Abstract][Full Text] [Related]
4. Functional importance of the C-terminus of the human norepinephrine transporter.
Distelmaier F; Wiedemann P; Brüss M; Bönisch H
J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
Reith ME; Wang LC; Dutta AK
J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relations of the first and fourth predicted extracellular linkers of the type IIa Na+/Pi cotransporter: I. Cysteine scanning mutagenesis.
Ehnes C; Forster IC; Kohler K; Bacconi A; Stange G; Biber J; Murer H
J Gen Physiol; 2004 Nov; 124(5):475-88. PubMed ID: 15504898
[TBL] [Abstract][Full Text] [Related]
7. A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding.
Sen N; Shi L; Beuming T; Weinstein H; Javitch JA
Neuropharmacology; 2005 Nov; 49(6):780-90. PubMed ID: 16216288
[TBL] [Abstract][Full Text] [Related]
8. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.
Melikian HE; Ramamoorthy S; Tate CG; Blakely RD
Mol Pharmacol; 1996 Aug; 50(2):266-76. PubMed ID: 8700133
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane domain VII of the human apical sodium-dependent bile acid transporter ASBT (SLC10A2) lines the substrate translocation pathway.
Hussainzada N; Banerjee A; Swaan PW
Mol Pharmacol; 2006 Nov; 70(5):1565-74. PubMed ID: 16899538
[TBL] [Abstract][Full Text] [Related]
10. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
Mash DC; Ouyang Q; Qin Y; Pablo J
J Neurosci Methods; 2005 Apr; 143(1):79-85. PubMed ID: 15763139
[TBL] [Abstract][Full Text] [Related]
11. Role of proline residues in the expression and function of the human noradrenaline transporter.
Paczkowski FA; Bryan-Lluka LJ
J Neurochem; 2004 Jan; 88(1):203-11. PubMed ID: 14675164
[TBL] [Abstract][Full Text] [Related]
12. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current.
Binda F; Lute BJ; Dipace C; Blakely RD; Galli A
Neuropharmacology; 2006 Mar; 50(3):354-61. PubMed ID: 16289633
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.
Paczkowski FA; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2001 Dec; 97(1):32-42. PubMed ID: 11744160
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.
Foley KF; Cozzi NV
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):457-61. PubMed ID: 12070759
[TBL] [Abstract][Full Text] [Related]
15. The role of the conserved GXXXRXG motif in the expression and function of the human norepinephrine transporter.
Sucic S; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):40-50. PubMed ID: 12480177
[TBL] [Abstract][Full Text] [Related]
16. Analysis by substituted cysteine scanning mutagenesis of the fourth transmembrane domain of the CXCR4 receptor in its inactive and active state.
Boulais PE; Escher E; Leduc R
Biochem Pharmacol; 2013 Feb; 85(4):541-50. PubMed ID: 23219524
[TBL] [Abstract][Full Text] [Related]
17. Design of novel synthetic MTS conjugates of bile acids for site-directed sulfhydryl labeling of cysteine residues in bile acid binding and transporting proteins.
Ray A; Banerjee A; Chang C; Khantwal CM; Swaan PW
Bioorg Med Chem Lett; 2006 Mar; 16(6):1473-6. PubMed ID: 16387497
[TBL] [Abstract][Full Text] [Related]
18. Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method.
Martin SS; Holleran BJ; Escher E; Guillemette G; Leduc R
Mol Pharmacol; 2007 Jul; 72(1):182-90. PubMed ID: 17446269
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.
Paczkowski FA; Bönisch H; Bryan-Lluka LJ
Pharmacogenetics; 2002 Mar; 12(2):165-73. PubMed ID: 11875370
[TBL] [Abstract][Full Text] [Related]
20. Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.
Javitch JA; Ballesteros JA; Chen J; Chiappa V; Simpson MM
Biochemistry; 1999 Jun; 38(25):7961-8. PubMed ID: 10387039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
